MedTrace Logo

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

NCT02691858 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-27

No results posted yet for this study

Summary

Intussusception is one of the most frequent causes of acute bowel and second most common cause of acute abdominal pain in pediatric age .95 % of cases are idiopathic, the rest are either due to pathological lead point or post operative. Treatment of intussusception must start with medical resuscitation, then radiological or operative reduction of intussusception.

Our surgery team has used hydrocortisone with the medical resuscitation to improve the success rate of pneumatic reduction and decrease the number of reduction trials.

Conditions

  • Intussusception

Interventions

DRUG

Hydrocortisone

10 mg/kg with Resuscitation before attempting pneumatic reduction, single dose with Resuscitation before attempting reduction

DRUG

Saline

100 ml with Resuscitation before attempting pneumatic reduction, single dose with Resuscitation before attempting reduction

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Gamal El Tagy, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02691858 on ClinicalTrials.gov